glp-1 obesity drug news today october 2025 Dozens of new drugs are coming: these are the ones to watch New GLP-1 Pill Foundayo (Orforglipron)

In one placebo-controlled 20-week trial, those taking a daily dose of 1.2 mg of liraglutide lost an average of about 11 lb, while those on 3 mg lost, on average, about 16 lb

A peptide studied for tissue support may only be present for a few hours after each dose, yet the cellular processes it nudges, such as new blood vessel formation or collagen activity, unfold over days and weeks of consistent dosing

Activation of MC1R is thought to initiate cyclic AMP mediated signaling cascades that may influence transcriptional regulators such as microphthalmia associated transcription factor, which is associated with enzymes involved in eumelanin production

[5] L-carnitine therapy (100 mg/kg -bodyweight/day) administered for 6 months significantly improved the autism severity as measured by CARS, but subsequent studies are recommended